WEBULL
WebtradeDownload

Tenet Healthcare (THC) Draws A Higher Price Target, Is It Fully Priced?

Simply Wall St · 2d ago

An analyst report from Argus recently increased its target price for Tenet Healthcare (THC) to US$284, putting fresh attention on the Dallas based hospital and ambulatory care operator’s valuation profile.

Tenet Healthcare’s share price has pulled back 0.69% over the past day to US$266.91. However, the 90-day share price return of 38.77% and 1-year total shareholder return of 35.95% point to strong momentum building around the stock’s story rather than fading interest.

Capitalize on the momentum around Tenet Healthcare by scanning a curated group of hospital and medical operators with resilient fundamentals using the list of solid balance sheet and fundamentals (25 results).

For Tenet Healthcare, the sharp 90 day climb sits next to a recent pause, which raises a simple tension. Is this mainly a sentiment swing, or does the current price better mirror the underlying business and its valuation today?

Most Popular Narrative: 3% Overvalued

Against Tenet Healthcare’s last close at $266.91, the most followed narrative anchors fair value at $260.00, which leaves the current quote a little above that reference point while still implying expectations for solid execution rather than collapse.

Management’s three part cost program, with traditional productivity, clinical efficiencies and technology or AI initiatives, has already reduced contract labor to about 2% of salaries wages and benefits and lowered certain analytics costs. This signals that the easiest savings are likely realized and that any slowdown in incremental efficiency gains could limit further adjusted EBITDA margin expansion.

See why 1 investors see Tenet Healthcare as 3% overvalued.

Result: Fair Value of $260.00 (OVERVALUED)

Still, Tenet Healthcare could surprise this bearish setup if USPI outpatient acuity and hospital EBITDA margins remain firm enough to offset payer mix and Conifer restructuring risks.

Find out about the key risks to this Tenet Healthcare narrative.

Another View on Tenet Healthcare’s Valuation

The bearish fair value of $260.00 leans heavily on softer earnings expectations. A different lens uses the P/E ratio. Tenet Healthcare trades on 9.6x earnings, compared with 19.9x for direct peers and 24.5x for the wider US Healthcare group, while the fair ratio sits at 19.1x.

This gap suggests investors either see real risk in the debt load and earnings outlook or have pushed pricing too far to the cautious side. The question for you is whether that discount reflects justified concern or a mispriced opportunity in plain sight.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:THC P/E Ratio as at Oct 2026
NYSE:THC P/E Ratio as at Oct 2026

Next Steps

Sentiment on Tenet Healthcare is split, which is exactly why acting early to review the numbers yourself matters. Use the full rundown of 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Tenet Healthcare?

Do not stop with Tenet Healthcare. Broaden your watchlist with a few focused stock ideas that match clear goals and disciplined risk control.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.